MedCline shown to significantly reduce nocturnal regurgitation and aspiration symptoms in post-esopogectomy patients. Results presented the American College of Surgeons (ACS) Clinical Congress.
The results of the most recent MedCline clinical trial, “Nocturnal Regurgitation after Esophagectomy Before and After Implementation of a Novel Sleep Positioning Device,” were presented at the American College of Surgeons (ACS) 2015 Clinical Congress. Conducted by the Department of Surgery, University of Southern California, Los Angeles California, the study results show MedCline to be an effective treatment for post-esophogectomy patients suffering with nocturnal regurgitation and aspiration symptoms. MedCline™ significantly decreased symptom severity and regurgitation, as well as showed marked improvements across all quality of life measures.
During an esophogectomy, part or all of the esophagus is removed and then reconstructed with organ tissue. Regurgitation and aspiration are common side-effects of the surgery , especially when laying flat, and can be devastating to a patient’s quality of life and clinical outcomes. Prior to the study, 35% of patients were using stacked pillows and 65% were sleeping on a wedge or a hospital bed to achieve an inclined sleep position. Even utilizing these inclining methods, all patients in the study continued to suffer nocturnal symptoms, including getting up frequently at night, episodes of waking up coughing, and regurgitation.
MedCline was shown to increase the maintenance of an inclined position with less difficulty of sliding down at night as reported by patients. Sleeping on MedCline resulted in a 65% reduction in symptom severity scores as measured by the Nocturnal GERD Symptom Severity and Impact Questionnaire (N-GSSIQ) showing notable improvements in getting up during the night, nocturnal coughing, and the severity of regurgitation. Additionally, 95% reported an overall improvement in sleep quality and improved energy throughout the day. The researchers theorized that sleep improvement would translate into an improved health-related quality of life and potentially a reduced frequency of post surgical pulmonary complications.
The findings of this study are consistent with previous studies evaluating MedCline for nocturnal GERD patients but extend its possible applications as an effective treatment for post-esphogectomy patients.
For more information about this and other MedCline clinical trial result, contact Aaron Clark at 858-605-1747.